Accreditation and Credit Statement
This activity has been planned and implemented in accordance with the accreditation and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Radiological Society of North America (RSNA) and the Association of University Radiologists (AUR). The RSNA is accredited by the ACCME to provide continuing medical education for physicians.
This live activity has been approved for AMA PRA Category 1 CreditTM.
The RSNA designates other activity (blended live and enduring materials) for a maximum of 92.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Radiologists, researchers, or other allied health professionals, trainees, and administrators in academic radiology.
The Accreditation Council for Continuing Medical Education (ACCME) requires that the Radiological Society of North America (RSNA), as an accredited provider of continuing medical education, obtain signed disclosure statements from meeting faculty, including committee members, program planners, presenters, and authors. The intent of this policy is not to prevent an individual with a financial relationship from participating; however, in accordance with ACCME standards, the RSNA has developed policies and procedures to manage identified conflicts of interest.
The ACCME further requires that the RSNA provide disclosure information to all attendees prior to the educational activity. Individuals who have or have had an affiliation or financial relationship with any commercial interest (within the previous 12 months or at the time the research was conducted) are listed in the program.
This indicates discussion of uses not approved by the FDA. The RSNA and AUR recognize that at educational meetings, faculty may discuss the application of some devices, materials, or pharmaceuticals that are not FDA approved. In keeping with the highest standards of professional integrity and ethics, RSNA and AUR require that faculty fully disclose to their audience that there will be discussion of the unlabeled use of a commercial product, device, or pharmaceutical that has not been approved for such purpose by the FDA.